» Articles » PMID: 35010295

Sarcopenia Identification During Comprehensive Geriatric Assessment

Overview
Publisher MDPI
Date 2022 Jan 11
PMID 35010295
Authors
Affiliations
Soon will be listed here.
Abstract

Comprehensive geriatric assessment (CGA) is a multidimensional diagnostic process enabling evaluation of elderly patients' physical and mental health status that implies implementation of the management targeted on the preservation of functional independence. Sarcopenia is a common but often underdiagnosed geriatric syndrome associated with increased likelihood of functional dependence and mortality risk. The main objectives of the study were the evaluation of sarcopenia prevalence in the patient group subjected to CGA with the upgraded EWGSOP2 algorithm considering muscle strength as the key criterion and usage of bioimpedance (BIA) muscle mass assessment. The study group consisted of 101 patients (76 women and 25 men) admitted for planned CGA to the Geriatrics Department of Wroclaw University Hospital. A diagnosis of sarcopenia was made according to the EWGSOP2 protocol. Body composition was determined with the bioimpedance technique. Functional status was assessed with ADLs from the VES-13 scale and additional questions. Sarcopenia was diagnosed in 16.8% of the study participants. Sarcopenic individuals presented worse functional status and impaired social activity. Muscle strength, gait speed and muscle mass below cut-off values were associated with dependence found in ADLs. Results showed that sarcopenia is a common impairment correlated with worse functional status and vulnerability to adverse outcomes. BIA can be treated as an accessible and accurate technique for muscle mass measurement in screening for sarcopenia, and the EWGSOP2 algorithm should be an essential part of the routine CGA procedure.

Citing Articles

Hand grip strength and quality of life among adults aged 50-90 years from South West Poland.

Kaczorowska A, Koziel S, Ignasiak Z Sci Rep. 2025; 15(1):882.

PMID: 39762442 PMC: 11704015. DOI: 10.1038/s41598-024-84923-x.


Correlates and predictors of sarcopenia among men with metastatic castrate-resistant prostate cancer.

Papadopoulos E, Wong A, Law S, Zhang L, Breunis H, Emmenegger U Can Urol Assoc J. 2024; 18(12):405-412.

PMID: 39037509 PMC: 11623326. DOI: 10.5489/cuaj.8803.


Obstacles to the Early Diagnosis and Management of Sarcopenia: Current Perspectives.

Ooi H, Welch C Clin Interv Aging. 2024; 19:323-332.

PMID: 38404480 PMC: 10893890. DOI: 10.2147/CIA.S438144.


Loss of Muscle Mass and Vulnerability in Institutionalized Older Adults.

Dantas Araujo M, Nobre T, Rosendo C, Lima F, de Araujo Nunes V, Torres G Int J Environ Res Public Health. 2023; 20(1).

PMID: 36612746 PMC: 9819833. DOI: 10.3390/ijerph20010426.


Patterns of Muscle-Related Risk Factors for Sarcopenia in Older Mexican Women.

Carrillo-Vega M, Perez-Zepeda M, Salinas-Escudero G, Garcia-Pena C, Reyes-Ramirez E, Espinel-Bermudez M Int J Environ Res Public Health. 2022; 19(16).

PMID: 36011874 PMC: 9408641. DOI: 10.3390/ijerph191610239.

References
1.
Roberts H, Denison H, Martin H, Patel H, Syddall H, Cooper C . A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing. 2011; 40(4):423-9. DOI: 10.1093/ageing/afr051. View

2.
Szulc P, Munoz F, Marchand F, Chapurlat R, Delmas P . Rapid loss of appendicular skeletal muscle mass is associated with higher all-cause mortality in older men: the prospective MINOS study. Am J Clin Nutr. 2010; 91(5):1227-36. DOI: 10.3945/ajcn.2009.28256. View

3.
Basile C, Della-Morte D, Cacciatore F, Gargiulo G, Galizia G, Roselli M . Phase angle as bioelectrical marker to identify elderly patients at risk of sarcopenia. Exp Gerontol. 2014; 58:43-6. DOI: 10.1016/j.exger.2014.07.009. View

4.
Smoliner C, Sieber C, Wirth R . Prevalence of sarcopenia in geriatric hospitalized patients. J Am Med Dir Assoc. 2014; 15(4):267-72. DOI: 10.1016/j.jamda.2013.11.027. View

5.
Zasadzka E, Pieczynska A, Trzmiel T, Pawlaczyk M . Polish Translation and Validation of the SARC-F Tool for the Assessment of Sarcopenia. Clin Interv Aging. 2020; 15:567-574. PMC: 7185989. DOI: 10.2147/CIA.S245074. View